Tenaya Therapeutics, Inc. (TNYA)
NASDAQ: TNYA · Real-Time Price · USD
0.8646
+0.0281 (3.36%)
At close: Jul 14, 2026, 4:00 PM EDT
0.8627
-0.0019 (-0.22%)
After-hours: Jul 14, 2026, 7:31 PM EDT
Tenaya Therapeutics Market Cap
Tenaya Therapeutics has a market cap or net worth of $187.62 million as of July 14, 2026. Its market cap has increased by 89.20% in one year.
Market Cap
187.62M
Enterprise Value
116.00M
1-Year Change
89.20%
Ranking
Category
Stock Price
$0.86
Market Cap Chart
Since July 30, 2021, Tenaya Therapeutics's market cap has decreased from $603.63M to $187.62M, a decrease of -68.92%. That is a compound annual growth rate of -20.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 187.62M | 21.79% |
| Dec 31, 2025 | 154.04M | 35.98% |
| Dec 31, 2024 | 113.29M | -48.67% |
| Dec 29, 2023 | 220.68M | 71.58% |
| Dec 30, 2022 | 128.62M | -83.56% |
| Dec 31, 2021 | 782.28M | 29.59% |
| Jul 30, 2021 | 603.63M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arcturus Therapeutics Holdings | 198.11M |
| Protalix BioTherapeutics | 196.59M |
| Caribou Biosciences | 190.92M |
| Q32 Bio | 190.08M |
| Acumen Pharmaceuticals | 189.96M |
| Outlook Therapeutics | 189.76M |
| Humacyte | 187.05M |
| Equillium | 183.99M |